Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04049201Not ApplicableCompleted

Interactive Tablet Compared to Oral Midazolam as Premedication in Preoperative Anxiety in Children

Role: lead

NCT03505814Not ApplicableUnknown

Interest of High Flow Nasal Cannula Oxygen Therapy in Pediatric Intensive Care Unit

Role: lead

NCT03105739Not ApplicableCompleted

Timing of Withdrawal of the Laryngeal Mask Airway (LMA) in Children

Role: lead

NCT03072329Not ApplicableCompleted

Neurostimulation in Pudendal Nerve Block

Role: lead

All 4 trials loaded